Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues
Today's clinical AIDS research is in trouble. Principal investigators are confronted with young and frequently highly knowledgeable patients. Many of these people with AIDS (PWAs) are often unwilling to adhere to the trial protocols. These PWAs believe they are ethically justified in breaching...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Cambridge Univ. Press
1996
|
| In: |
Cambridge quarterly of healthcare ethics
Year: 1996, Volume: 5, Issue: 3, Pages: 400-409 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1827968338 | ||
| 003 | DE-627 | ||
| 005 | 20221220052634.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221220s1996 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0963180100007209 |2 doi | |
| 035 | |a (DE-627)1827968338 | ||
| 035 | |a (DE-599)KXP1827968338 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Schüklenk, Udo |e VerfasserIn |4 aut | |
| 109 | |a Schüklenk, Udo |a Schuklenk, Udo |a Schülenk, Udo | ||
| 245 | 1 | 0 | |a Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues |
| 264 | 1 | |c 1996 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Today's clinical AIDS research is in trouble. Principal investigators are confronted with young and frequently highly knowledgeable patients. Many of these people with AIDS (PWAs) are often unwilling to adhere to the trial protocols. These PWAs believe they are ethically justified in breaching trial protocols because they do not consider themselves true volunteers in such trials. PWAs argue that they do not really volunteer because existing legislation prevents them from buying and using experimental drugs or from testing alternative treatment strategies. Their only access to such agents is participation in clinical trials. | ||
| 601 | |a Patient | ||
| 601 | |a Experiment | ||
| 700 | 1 | |a Hogan, Carlton |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cambridge quarterly of healthcare ethics |d Cambridge : Cambridge Univ. Press, 1992 |g 5(1996), 3, Seite 400-409 |h Online-Ressource |w (DE-627)306655039 |w (DE-600)1499985-7 |w (DE-576)081985010 |x 1469-2147 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:1996 |g number:3 |g pages:400-409 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/S0963180100007209 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/abs/patient-access-to-experimental-drugs-and-aids-clinical-trial-designs-ethical-issues/DB3A0EC7B24097367F34D36879214A41 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 5 |j 1996 |e 3 |h 400-409 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4235373242 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1827968338 | ||
| LOK | |0 005 20221220052634 | ||
| LOK | |0 008 221220||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-06#D753CFF7983F1DBEE3621225F3EAEF41CE3364A3 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||